TEVA PHARMACEUTICALS USA
Lobbying client. Federal LDA filings.
- Source id
206634- General description
- Generic and biosimilar manufacturer.
- State
- DC
- Country
- US
- Principal place of business
- US
- Government-entity client
- false
- Effective date
- 2020-06-16
- Total spend (across 1 ingested filings)
- $60,000
Filings (1) — $60,000
| Posted | Type | Year | Lobbying firm | Income |
|---|---|---|---|---|
| 2026-04-21 | Q1 | 2026 | CAPITOL HILL CONSULTING GROUP | $60,000 |
Connected on the graph
13 typed relationships in the influence graph — 8 inbound, 5 outbound, grouped by type.
lobbied for (6)
| date | dir | entity | amount | role | source |
|---|---|---|---|---|---|
| — | ← | Christopher Davis | — | lda_lobbyist_client | |
| — | ← | Kimberlee Trzeciak | — | lda_lobbyist_client | |
| — | ← | Emily Elizabeth Wilkinson-Holland | — | lda_lobbyist_client | |
| — | ← | Brian Sutter | — | lda_lobbyist_client | |
| — | ← | Megan Sussman Herber | — | lda_lobbyist_client | |
| — | ← | Elliot Vice | — | lda_lobbyist_client |
lobbies on bill (5)
| date | dir | entity | amount | role | source |
|---|---|---|---|---|---|
| 2026-01-01 | → | Skinny Labels, Big Savings Act S 43 · introduced 2025-01-09 · latest action: Read twice and referred to the Committee on the Judiciary. | — | S 43 | lobbying_bill_mention |
| 2026-01-01 | → | Interagency Patent Coordination and Improvement Act of 2025 S 1097 · introduced 2025-03-24 · latest action: Placed on Senate Legislative Calendar under General Orders. Calendar No. 41. | — | S 1097 | lobbying_bill_mention |
| 2026-01-01 | → | Preserve Access to Affordable Generics and Biosimilars Act S 1096 · introduced 2025-03-24 · latest action: Placed on Senate Legislative Calendar under General Orders. Calendar No. 46. | — | S 1096 | lobbying_bill_mention |
| 2026-01-01 | → | Stop STALLING Act S 1095 · introduced 2025-03-24 · latest action: Placed on Senate Legislative Calendar under General Orders. Calendar No. 45. | — | S 1095 | lobbying_bill_mention |
| 2026-01-01 | → | To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in ge HR 1843 · introduced 2025-03-05 · latest action: Referred to the House Committee on Energy and Commerce. | — | HR 1843 | lobbying_bill_mention |
co acted on bill with (1)
| date | dir | entity | amount | role | source |
|---|---|---|---|---|---|
| 2026-01-01 | ← | Hickenlooper, John W. | — | s43-119 | lda_filing |
lobbies for (1)
| date | dir | entity | amount | role | source |
|---|---|---|---|---|---|
| 2026-01-01 | ← | FAEGRE DRINKER BIDDLE & REATH LLP | $60,000 | lda_filing |